4//SEC Filing
Sunshine Biopharma, Inc 4
Accession 0001128732-16-000025
$SBFMCIK 0001402328operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 11:35 AM ET
Size
5.1 KB
Accession
0001128732-16-000025
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Other
Common Stock
2016-07-08$0.00/sh+321,305,416$835,394→ 351,876,192 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)
Footnotes (1)
- [F1]Issuer issued 321,305,416 shares of its Common Stock to Advanomics Corporation, a related party, in consideration for cancellation of two promissory notes payable to Advanomics Corporation in the aggregate amount of $835,394.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeoperating
IncorporatedCO
Related Parties
1- filerCIK 0001402328
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 11:35 AM ET
- Size
- 5.1 KB